Avoro Capital Advisors LLC 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:05 am Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,858,888 6.100% | -6,112 (-0.21%) | Filing |
| 2023-02-14 09:34 am Sale | 2022-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,865,000 6.300% | -170,000 (-5.60%) | Filing |
| 2022-02-11 10:02 am Purchase | 2021-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 3,035,000 6.700% | 185,000 (+6.49%) | Filing |
| 2021-02-12 08:08 am Purchase | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,850,000 6.400% | 2,850,000 (New Position) | Filing |